loadpatents
Patent applications and USPTO patent grants for Brookings; Daniel Christopher.The latest application filed is for "fused pentacyclic imidazole derivatives as modulators of tnf activity".
Patent | Date |
---|---|
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20210252012 - Brookings; Daniel Christopher ;   et al. | 2021-08-19 |
Spirocyclic Indane Analogues as IL-17 Modulators App 20210228547 - Brace; Gareth Neil ;   et al. | 2021-07-29 |
Fused Pentacyclic Imidazole Derivatives App 20210155637 - De Haro Garcia; Teresa ;   et al. | 2021-05-27 |
Mechanism Of Action App 20210140972 - O'CONNELL; James Philip ;   et al. | 2021-05-13 |
Fused pentacyclic imidazole derivatives as modulators of TNF activity Grant 10,980,814 - Brookings , et al. April 20, 2 | 2021-04-20 |
Fused pentacyclic imidazole derivatives as modulators of TNF activity Grant 10,953,019 - Brown , et al. March 23, 2 | 2021-03-23 |
Fused pentacyclic imidazole derivatives Grant 10,906,919 - De Haro Garcia , et al. February 2, 2 | 2021-02-02 |
Methods of identifying signaling modulators of the trimeric TNFa Grant 10,883,996 - O'Connell , et al. January 5, 2 | 2021-01-05 |
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20200046723 - Brookings; Daniel Christopher ;   et al. | 2020-02-13 |
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20200022988 - Brown; Julien Alistair ;   et al. | 2020-01-23 |
Fused Pentacyclic Imidazole Derivatives App 20190367535 - De Haro Garcia; Teresa ;   et al. | 2019-12-05 |
Fused pentacyclic imidazole derivatives Grant 10,202,405 - De Haro Garcia , et al. Feb | 2019-02-12 |
Triazolopyridazine derivatives as modulators of TNF activity Grant 10,053,464 - Brookings August 21, 2 | 2018-08-21 |
Mechanism Of Action App 20180203016 - O'CONNELL; James Philip ;   et al. | 2018-07-19 |
Benzotriazole derivatives as modulators of TNF activity Grant 9,957,255 - Brookings , et al. May 1, 2 | 2018-05-01 |
Imidazopyrimidine derivatives as modulators of TNF activity Grant 9,932,342 - Ali , et al. April 3, 2 | 2018-04-03 |
Pyrazolopyridine derivatives as modulators of TNF activity Grant 9,902,720 - Brookings , et al. February 27, 2 | 2018-02-27 |
Imidazopyridazine derivatives as modulators of TNF activity Grant 9,873,703 - Ali , et al. January 23, 2 | 2018-01-23 |
Fused imidazole and pyrazole derivatives as modulators of TNF activity Grant 9,868,749 - Alexander , et al. January 16, 2 | 2018-01-16 |
Triazolopyridine derivatives as modulators of TNF activity Grant 9,850,240 - Brookings , et al. December 26, 2 | 2017-12-26 |
Fused Pentacyclic Imidazole Derivatives App 20170305932 - De Haro Garcia; Teresa ;   et al. | 2017-10-26 |
Imidazotriazine derivatives as modulators of TNF activity Grant 9,714,251 - Brookings , et al. July 25, 2 | 2017-07-25 |
Triazolopyridazine Derivatives as Modulators of TNF Activity App 20170129894 - Brookings; Daniel Christopher | 2017-05-11 |
Pyrazolopyridine Derivatives as Modulators of TNF Activity App 20170081321 - Brookings; Daniel Christopher ;   et al. | 2017-03-23 |
TNF -.alpha. modulating benzimidazoles Grant 9,550,737 - Brookings , et al. January 24, 2 | 2017-01-24 |
Imidazopyridazine Derivatives as Modulators of TNF Activity App 20160376275 - ALI; Mezher Hussein ;   et al. | 2016-12-29 |
Imidazotriazine Derivatives as Modulators of TNF Activity App 20160376276 - Brookings; Daniel Christopher ;   et al. | 2016-12-29 |
Substituted imidazo[1,2-a]pyrazines as TNF activity modulators Grant 9,475,820 - Bentley , et al. October 25, 2 | 2016-10-25 |
Triazolopyridine Derivatives As Modulators of TNF Activity App 20160304512 - Brookings; Daniel Christopher ;   et al. | 2016-10-20 |
Benzotriazole Derivatives as Modulators of TNF Activity App 20160297799 - Brookings; Daniel Christopher ;   et al. | 2016-10-13 |
Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity App 20160297837 - Alexander; Rikki Peter ;   et al. | 2016-10-13 |
Imidazopyrimidine Derivatives As Modulators of TNF Activity App 20160297827 - Ali; Mezher Hussein ;   et al. | 2016-10-13 |
Therapeutically active oxazoline derivatives Grant 9,382,263 - Kulisa , et al. July 5, 2 | 2016-07-05 |
Imidazopyridine derivatives as modulators of TNF activity Grant 9,309,243 - Bentley , et al. April 12, 2 | 2016-04-12 |
Therapeutically active fused pyrimidine derivatives Grant 9,227,984 - Brookings , et al. January 5, 2 | 2016-01-05 |
Therapeutically Active Oxazoline Derivatives App 20150274748 - Kulisa; Claire Louise ;   et al. | 2015-10-01 |
Therapeutically active thiazolo-pyrimidine derivatives Grant 9,096,614 - Brookings , et al. August 4, 2 | 2015-08-04 |
Imidazopyridine Derivatives as Modulators of TNF Activity App 20150203486 - Bentley; Jonathan Mark ;   et al. | 2015-07-23 |
Imidazopyrazine Derivatives as Modulators of TNF Activity App 20150191482 - Bentley; Jonathan Mark ;   et al. | 2015-07-09 |
TNF -Alpha Modulating Benzimidazoles App 20150152065 - Brookings; Daniel Christopher ;   et al. | 2015-06-04 |
Quinoline derivatives as kinase inhibitors Grant 9,029,392 - Parton , et al. May 12, 2 | 2015-05-12 |
Therapeutically Active Thiazolo-Pyrimidine Derivatives App 20140315885 - Brookings; Daniel Christopher ;   et al. | 2014-10-23 |
Therapeutically Active Fused Pyrimidine Derivatives App 20140309222 - Brookings; Daniel Christopher ;   et al. | 2014-10-16 |
Thieno-pyridine derivatives as MEK inhibitors Grant 8,637,491 - Johnson , et al. January 28, 2 | 2014-01-28 |
Thieno-pyridine derivatives as MEK inhibitors Grant 8,604,051 - Hutchings , et al. December 10, 2 | 2013-12-10 |
Quinoline and Quinoxaline Derivatives as Kinase Inhibitors App 20130296338 - Parton; Andrew Harry ;   et al. | 2013-11-07 |
Thieno-pyridine derivatives as MEK inhibitors Grant 8,487,101 - Brookings , et al. July 16, 2 | 2013-07-16 |
Thieno-pyridine Derivatives As Mek Inhibitors App 20130150573 - Hutchings; Clive Martin ;   et al. | 2013-06-13 |
Thieno-pyridine derivatives as MEK inhibitors Grant 8,394,822 - Hutchings , et al. March 12, 2 | 2013-03-12 |
Thieno-pyridine derivatives as MEK inhibitors Grant 8,350,037 - Johnson , et al. January 8, 2 | 2013-01-08 |
Thieno-pyridine Derivatives As Mek Inhibitors App 20120329774 - Hutchings; Clive Martin ;   et al. | 2012-12-27 |
Fused thiophene derivatives as kinase inhibitors Grant 8,324,204 - Alexander , et al. December 4, 2 | 2012-12-04 |
Thieno-pyridine derivatives as MEK inhibitors Grant 8,283,359 - Hutchings , et al. October 9, 2 | 2012-10-09 |
Thieno-pyridine Derivatives As Mek Inhibitors App 20110172191 - Johnson; James Andrew ;   et al. | 2011-07-14 |
Fused thiazole derivatives as kinase inhibitors Grant 7,888,344 - Alexander , et al. February 15, 2 | 2011-02-15 |
Thieno-pyridine Derivatives As Mek Inhibitors App 20110021558 - Brookings; Daniel Christopher ;   et al. | 2011-01-27 |
Fused Thiophene Derivatives as Kinase Inhibitors App 20100305066 - Alexander; Rikki Peter ;   et al. | 2010-12-02 |
Bicyclic heteroaromatic derivatives Grant 7,763,729 - Brookings , et al. July 27, 2 | 2010-07-27 |
Thieno-pyridine Derivatives As Mek Inhibitors App 20100179124 - Johnson; James Andrew ;   et al. | 2010-07-15 |
Novel Aminothienopyridinone Derivatives Processes for Preparing Them and Pharmaceutical Compositions Thereof App 20100179185 - Davis; Jeremy Martin ;   et al. | 2010-07-15 |
Fused Thiophene Derivatives As Mek Inhibitors App 20090264411 - Laing; Victoria Elizabeth ;   et al. | 2009-10-22 |
Bicyclic heteroaromatic compounds as kinase inhibitors Grant 7,592,455 - Brookings , et al. September 22, 2 | 2009-09-22 |
Thieno-pyridine Derivatives As Mek Inhibitors App 20090149437 - Hutchings; Clive Martin ;   et al. | 2009-06-11 |
Thienopyridone derivatives as kinase inhibitors Grant 7,521,460 - Brookings , et al. April 21, 2 | 2009-04-21 |
Bicyclic Heteroaromatic Derivatives App 20090042877 - Brookings; Daniel Christopher ;   et al. | 2009-02-12 |
Fused Thiazole Derivatives as Kinase Inhibitors App 20080306060 - Alexander; Rikki Peter ;   et al. | 2008-12-11 |
Bicyclic heteroaromatic compounds as kinase inhibitors Grant 7,456,286 - Brookings , et al. November 25, 2 | 2008-11-25 |
Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors Grant 7,423,047 - Brookings , et al. September 9, 2 | 2008-09-09 |
Pyridine and pyrimidine derivatives Grant 7,323,464 - Davis , et al. January 29, 2 | 2008-01-29 |
Bicyclic oxopyridine and oxopyrimidine derivatives Grant 7,176,215 - Davis , et al. February 13, 2 | 2007-02-13 |
Thienopyridone derivatives as kinase inhibitors App 20060247269 - Brookings; Daniel Christopher ;   et al. | 2006-11-02 |
Bicyclic heteroaromatic compounds as kinase inhibitors App 20060122212 - Brookings; Daniel Christopher ;   et al. | 2006-06-08 |
Bicyclic heteroaromatic compounds as kinase inhibitors App 20060025428 - Brookings; Daniel Christopher ;   et al. | 2006-02-02 |
Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors App 20060004025 - Brookings; Daniel Christopher ;   et al. | 2006-01-05 |
Pyridine and pyrimidine derivatives App 20050080258 - Davis, Jeremy Martin ;   et al. | 2005-04-14 |
Bicyclic oxopyridine and oxopyrimidine derivatives App 20040254200 - Davis, Jeremy Martin ;   et al. | 2004-12-16 |
Antimicrobial agents Grant 6,716,878 - Todd , et al. April 6, 2 | 2004-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.